Medical devices, healthcare technology and the business of care
DEVICE CATEGORY · QNH

Immunohistochemistry Test, Dna Mismatch Repair (Mmr) Protein Assay

The DNA Mismatch Repair Protein Antibody is a qualitative immunohistochemical antibody intended for the assessment of mismatch repair (MMR) proteins in human clinical tissue specimens. The DNA Mismatch Repair Protein Antibody is indicated as an aid in identifying patients eligible for treatment with specific FDA approved therapeutic drugs.

Product / regulatory recordCompanyPathwayDecision dateSource
Ventana Medical SystemsPMA supplementOct 8, 2026FDA
Ventana Medical Systems, Inc. (Roche Tissue Diagnostics)PMA supplementOct 8, 2026FDA
Agilent Technologies, Inc.PMA supplementSep 11, 2026FDA
Ventana Medical SystemsPMA supplementJan 6, 2026FDA
Ventana Medical Systems, Inc. (Roche Tissue Diagnostics)PMA supplementJan 6, 2026FDA
Agilent Technologies, Inc.PMA approvalAug 15, 2025FDA
Ventana Medical Systems, Inc. (Roche Tissue Diagnostics)PMA approvalAug 17, 2021FDA
Ventana Medical SystemsPMA approvalApr 22, 2021FDA
Source information

Follow the FDA links to view the original records.

All device categories